Literature DB >> 8408551

Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates.

S H Siddiqi1, L B Heifets, M H Cynamon, N M Hooper, A Laszlo, J P Libonati, P J Lindholm-Levy, N Pearson.   

Abstract

A multicenter study was done to investigate the accuracy and reproducibility of a method for determining the MICs of antimicrobial agents against the Mycobacterium avium complex in 7H12 broth with the BACTEC system. In phase I, with eight drugs and 10 strains, intralaboratory reproducibility was 95.7 to 100%, allowing a 1-dilution difference upon repeat testing. The results of phase II testing with 41 additional strains were consistent with those obtained in phase I, with good interlaboratory reproducibility. The radiometric method was validated by sampling and plating of the same broth cultures and determining, by the number of CFU per milliliter, the lowest drug concentration that inhibited more than 99% of the initial bacterial population. Three test concentrations of each drug and the tentative interpretation of results are proposed. Radiometric MIC determination has the potential to become the method of choice for clinical microbiology laboratories and evaluation of new agents for the treatment of M. avium infections, both pulmonary and disseminated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408551      PMCID: PMC265756          DOI: 10.1128/jcm.31.9.2332-2338.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  S H Siddiqi; J P Libonati; G Middlebrook
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

2.  Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis.

Authors:  L B Heifets; M D Iseman; P J Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

3.  Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.

Authors:  T E Kiehn; F F Edwards; P Brannon; A Y Tsang; M Maio; J W Gold; E Whimbey; B Wong; J K McClatchy; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

Review 4.  Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex.

Authors:  L S Young; C B Inderlied; O G Berlin; M S Gottlieb
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

5.  Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing.

Authors:  C R Horsburgh; U G Mason; L B Heifets; K Southwick; J Labrecque; M D Iseman
Journal:  Am Rev Respir Dis       Date:  1987-02

6.  Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens.

Authors:  G D Roberts; N L Goodman; L Heifets; H W Larsh; T H Lindner; J K McClatchy; M R McGinnis; S H Siddiqi; P Wright
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

7.  Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.

Authors:  L B Heifets; P J Lindholm-Levy; M Flory
Journal:  Am Rev Respir Dis       Date:  1991-02

8.  The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey.

Authors:  R J O'Brien; L J Geiter; D E Snider
Journal:  Am Rev Respir Dis       Date:  1987-05

9.  Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods.

Authors:  S H Siddiqi; J E Hawkins; A Laszlo
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

10.  Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.

Authors:  C H Fenlon; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

View more
  26 in total

1.  Mycobacterium malmoense in Italy: the modern Norman invasion?

Authors:  E Tortoli; C Piersimoni; A Bartoloni; C Burrini; A P Callegaro; G Caroli; D Colombrita; A Goglio; A Mantella; C P Tosi; M T Simonetti
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

2.  Growth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis.

Authors:  Nicole M Parrish; Chiew G Ko; James D Dick; Paul B Jones; Jay L E Ellingson
Journal:  Clin Med Res       Date:  2004-05

3.  Characterization of mycobacterial isolates phylogenetically related to, but different from Mycobacterium simiae.

Authors:  E Tortoli; C Piersimoni; P Kirschner; A Bartoloni; C Burrini; C Lacchini; A Mantella; G Muzzi; C P Tosi; V Penati; C Scarparo; M T Simonetti; E C Böttger
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 4.  Antimycobacterial susceptibility testing: present practices and future trends.

Authors:  C B Inderlied
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 5.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

6.  Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery.

Authors:  T M Arain; A E Resconi; M J Hickey; C K Stover
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

7.  Synergic Antibacterial Effect of Curcumin with Ampicillin; Free Drug Solutions in Comparison with SLN Dispersions.

Authors:  Faezeh Alihosseini; Shirzad Azarmi; Solmaz Ghaffari; Setareh Haghighat; Seyed Mahdi Rezayat Sorkhabadi
Journal:  Adv Pharm Bull       Date:  2016-09-25

8.  Multisite reproducibility of results obtained by two broth dilution methods for susceptibility testing of Mycobacterium avium complex.

Authors:  Gail L Woods; Natalie Williams-Bouyer; Richard J Wallace; Barbara A Brown-Elliott; Frank G Witebsky; Patricia S Conville; Marianne Plaunt; Geraldine Hall; Priscilla Aralar; Clark Inderlied
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Isolation of the newly described species Mycobacterium celatum from AIDS patients.

Authors:  E Tortoli; C Piersimoni; D Bacosi; A Bartoloni; F Betti; L Bono; C Burrini; G De Sio; C Lacchini; A Mantella
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

Review 10.  Mycobacterium celatum pulmonary infection in the immunocompetent: case report and review.

Authors:  Claudio Piersimoni; Pier Giorgio Zitti; Domenico Nista; Stefano Bornigia
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.